Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q2 2023 Results Conference Call August 14, 2023 8:30 AM ET Company Participants Nichol Ochsner - Vice President of Investor Relations Christal Mickle - Co-Founder, Chief Product Development Officer and Interim CEO LaDuane Clifton - Chief Financial Officer Josh Schafer - Chief Commercial Officer and Executive Vice President, Business Development Conference Call Participants Oren Livnat - H.C. Wainwright Sumant Kulkarni - Canaccord Jonathan Aschoff - ROTH MKM Operator Go ...